This educational resource is independently supported by GSK. All content was developed by SES in collaboration with an expert steering committee. Funders were allowed no influence on the content of this resource.

During the European School of Haematology (ESH) 4th How to Diagnose and Treat: CML/MPN conference, the MPN Hub hosted a symposium titled “Anemia in myelofibrosis: Sequencing therapies to optimize patient outcomes.”

The symposium closed with a panel Q&A session with live audience participation. The panelists, Jean-Jacques Kiladjian, Francesco Passamonti, and Paola Guglielmelli, shared their perspectives on the optimal sequencing of therapies for patients with myelofibrosis-related anemia, the use of iron chelation therapy, potential future combination therapies, and the use of anemia supportive agents.

Hosted on Acast. See acast.com/privacy for more information.